We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$219M
AUM Growth
-$44.2M
Cap. Flow
-$47.9M
Cap. Flow %
-21.86%
Top 10 Hldgs %
76.37%
Holding
74
New
22
Increased
4
Reduced
17
Closed
22

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$9.01M
2
TSLX icon
Sixth Street Specialty
TSLX
+$8.89M
3
SCTY
SolarCity Corporation
SCTY
+$3.46M
4
LRMR icon
Larimar Therapeutics
LRMR
+$2.96M
5
ZEN
ZENDESK INC
ZEN
+$2.59M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$19.6M
2
VIPS icon
Vipshop
VIPS
+$10M
3
TWTR
Twitter, Inc.
TWTR
+$9.01M
4
ZU
ZULILY INC CLASS A COMMON STOCK
ZU
+$4.83M
5
DATA
Tableau Software, Inc.
DATA
+$4.08M

Sector Composition

Rank Sector Weight
1 Communication Services 44.37%
2 Healthcare 10.63%
3 Technology 10.02%
4 Financials 9.5%
5 Industrials 4.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOAH
26
Noah Holdings
NOAH
$577M
$1.07M 0.49%
45,684
-55,092
-55% -$1.16M
TTOO
27
DELISTED
T2 Biosystems, Inc
TTOO
$997K 0.45%
+13
New +$1.21M
AWAY
28
DELISTED
HOMEAWAY INC COM
AWAY
$890K 0.41%
29,491
-140,000
-83% -$4.05M
OMED
29
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$873K 0.4%
+33,845
New +$858K
XLRN
30
DELISTED
Acceleron Pharma
XLRN
$862K 0.39%
22,647
-19,902
-47% -$791K
CRTO icon
31
Criteo S.A. Ordinary Shares
CRTO
$1.08B
$747K 0.34%
+18,900
New +$786K
AERI
32
DELISTED
Aerie Pharmaceuticals
AERI
$736K 0.34%
23,475
– –
XENT
33
DELISTED
Intersect ENT, Inc
XENT
$706K 0.32%
+27,330
New +$625K
TVRD
34
Tvardi Therapeutics
TVRD
$19.2M
$600K 0.27%
1,659
-555
-25% -$210K
XNET
35
Xunlei
XNET
$337M
$573K 0.26%
+90,003
New +$655K
TPST icon
36
Tempest Therapeutics
TPST
$13.7M
$569K 0.26%
+6
New +$799K
MKTO
37
DELISTED
MARKETO INC COM STK (DE)
MKTO
$475K 0.22%
18,532
+1,679
+10% +$50.1K
ESPR
38
DELISTED
Esperion Therapeutics
ESPR
$440K 0.2%
+4,756
New +$307K
VTLE
39
DELISTED
Vital Energy
VTLE
$384K 0.18%
1,474
-3,750
-72% -$852K
IMDZ
40
DELISTED
Immune Design Corp.
IMDZ
$365K 0.17%
17,312
-25,500
-60% -$665K
PAYC icon
41
Paycom
PAYC
$7.53B
$349K 0.16%
+10,877
New +$323K
RKUS
42
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$256K 0.12%
19,887
-18,000
-48% -$202K
JMEI
43
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$221K 0.1%
+1,400
New +$192K
HNRG icon
44
Hallador Energy
HNRG
$672M
$218K 0.1%
+18,664
New +$217K
NVAX icon
45
Novavax
NVAX
$1.19B
$174K 0.08%
+1,054
New +$171K
MOBL
46
DELISTED
MobileIron, Inc.
MOBL
$162K 0.07%
+17,508
New +$159K
VTAE
47
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$159K 0.07%
+13,537
New +$183K
BIND
48
DELISTED
BIND THERAPEUTICS INC
BIND
$69K 0.03%
+12,500
New +$76.8K
CDNA icon
49
CareDx
CDNA
$2.26B
$57K 0.03%
+10,244
New +$67.6K
TOVX icon
50
Theriva Biologics
TOVX
$9.68M
$52K 0.02%
3
– –
1
2
3

Similar funds

FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $148M AUM 20.92% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
RCM
Rockbridge Capital Management Alexandria, Virginia $149M AUM 1.06% 1-Year Est. Return
AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
JWM
Jacksonville Wealth Management Jacksonville, Florida $148M AUM 23.77% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $149M AUM 10.03% 1-Year Est. Return

Hamilton Lane Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Hamilton Lane Advisors held 74 positions worth $219M, down 17% from $263M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Hamilton Lane Advisors withdrew a net $47.9M in Q1 2015, closing 22 positions and reducing 17 holdings. Its most notable exit was Tableau Software, Inc., an estimated $4.08M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 44% of assets, down from 45% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Hamilton Lane Advisors opened a new position in Agios Pharmaceuticals worth $7.58M.

  • Hamilton Lane Advisors's largest Q1 2015 buy was Agios Pharmaceuticals: 80,439 shares worth $7.58M.
  • Hamilton Lane Advisors added most to SolarCity Corporation in Q1 2015, an estimated $3.46M increase.
  • Hamilton Lane Advisors's biggest Q1 2015 reduction was Meta Platforms (Facebook), cutting an estimated $19.6M.
  • Hamilton Lane Advisors fully exited Tableau Software, Inc. in Q1 2015, selling an estimated $4.08M.
  • Hamilton Lane Advisors's ten largest holdings make up 76% of its $219M portfolio in Q1 2015.
  • Hamilton Lane Advisors opened 22 new positions and closed 22 in Q1 2015.
  • Hamilton Lane Advisors's portfolio value fell 17% quarter-over-quarter to $219M.

Based on Hamilton Lane Advisors's 13F filing for Q1 2015, filed 8 Apr 2015.